Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 282

Similar articles for PubMed (Select 16444460)

1.
2.

[Antiphospholipid antibodies as risk factor for venous thromboembolism].

Windyga J.

Pol Arch Med Wewn. 2002 Nov;108(5):1065-70. Polish.

PMID:
12685247
3.

Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population-based prospective study.

Runchey SS, Folsom AR, Tsai MY, Cushman M, McGovern PD.

Br J Haematol. 2002 Dec;119(4):1005-10.

PMID:
12472581
4.

Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis.

Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH, Stampfer MJ.

Ann Intern Med. 1992 Dec 15;117(12):997-1002.

PMID:
1443986
6.

Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism.

Zanon E, Prandoni P, Vianello F, Saggiorato G, Carraro G, Bagatella P, Girolami A.

Thromb Res. 1999 Nov 15;96(4):269-74.

PMID:
10593429
7.

The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.

Jiménez D, Díaz G, Marín E, Vidal R, Sueiro A, Yusen RD.

Thromb Haemost. 2006 Mar;95(3):562-6.

PMID:
16525588
8.

The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.

Prandoni P, Noventa F, Ghirarduzzi A, Pengo V, Bernardi E, Pesavento R, Iotti M, Tormene D, Simioni P, Pagnan A.

Haematologica. 2007 Feb;92(2):199-205.

9.

Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis.

Sidelmann JJ, Sjøland JA, Gram J, Bertelsen V, Mourits-Andersen T, Münster H, Münster AM, Jespersen J.

Scand J Clin Lab Invest. 2007;67(3):270-9.

PMID:
17454841
10.

Antiphosphatidylinositol antibody in deep venous thrombosis patients.

Panarelli P, Viola-Magni MP, Albi E.

Int J Immunopathol Pharmacol. 2003 Jan-Apr;16(1):61-6.

PMID:
12578733
11.

Risk of thromboembolism after cerebral venous thrombosis.

Maqueda VM, Thijs V.

Eur J Neurol. 2006 Mar;13(3):302-5.

PMID:
16618351
12.

Anticardiolipin antibodies associated with alcoholic cardiomyopathy.

de Godoy JM, de Godoy MF, Braile DM.

Clin Cardiol. 2009 Jun;32(6):E63-4. doi: 10.1002/clc.20298.

PMID:
18666184
13.

Long-term outcomes of deep-vein thrombosis.

Beyth RJ, Cohen AM, Landefeld CS.

Arch Intern Med. 1995 May 22;155(10):1031-7.

PMID:
7748045
14.

Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease.

Puisieux F, de Groote P, Masy E, Di Pompeo C, Millaire A, Bouillanne O, Jude B, Dewailly P, Ducloux G.

Am J Med. 2000 Dec 1;109(8):635-41.

PMID:
11099683
15.

Anticardiolipin antibodies as a risk factor of atherosclerosis in intermittent claudication.

de Godoy JM, Batigália F, de Godoy MR, Brandão AC, Souza DR.

Angiology. 2004 Jul-Aug;55(4):357-9.

PMID:
15258681
16.

[Value of an extensive biological study in venous or arterial thromboses].

Tazi Z, Cacoub P, Koskas F, Chabanel A, Chadefaux-Vekemans B, Horellou MH, Viard JP, Piette JC, Kieffer E, Godeau P.

Presse Med. 1996 Mar 30;25(11):531-6. French.

PMID:
8731796
17.

Superficial thrombophlebitis and anticardiolipin antibodies--report of association.

de Godoy JM, Batigália F, Braile DM.

Angiology. 2001 Feb;52(2):127-9.

PMID:
11228085
18.

Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.

Sanmarco M, Gayet S, Alessi MC, Audrain M, de Maistre E, Gris JC, de Groot PG, Hachulla E, Harlé JR, Sié P, Boffa MC.

Thromb Haemost. 2007 Jun;97(6):949-54.

PMID:
17549297
19.

Portal vein thrombosis in cirrhotics: related with anticardiolipin antibodies?

Oksüzoglu G, Bayraktar Y, Arslan S, Celik I, Arslan M, Sivri B, Kirazli S, Kayhan B.

Hepatogastroenterology. 2003 Sep-Oct;50(53):1527-30.

PMID:
14571778
20.

Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism.

Zanon E, Saggiorato G, Ramon R, Girolami A, Pagnan A, Prandoni P.

Thromb Haemost. 2004 Feb;91(2):255-8.

PMID:
14961151
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk